These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 38225412)

  • 1. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
    Pandi-Perumal SR; BaHammam AS; Brown GM; Spence DW; Bharti VK; Kaur C; Hardeland R; Cardinali DP
    Neurotox Res; 2013 Apr; 23(3):267-300. PubMed ID: 22739839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
    Onaolapo OJ; Onaolapo AY; Olowe OA; Udoh MO; Udoh DO; Nathaniel TI
    Curr Neuropharmacol; 2020; 18(7):563-577. PubMed ID: 31885352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging.
    Bocheva G; Bakalov D; Iliev P; Tafradjiiska-Hadjiolova R
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.
    Melhuish Beaupre LM; Brown GM; Gonçalves VF; Kennedy JL
    Transl Psychiatry; 2021 Jun; 11(1):339. PubMed ID: 34078880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V
    Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
    Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiapoptotic activity of melatonin in neurodegenerative diseases.
    Wang X
    CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders.
    Anderson G; Maes M
    CNS Neurol Disord Drug Targets; 2014; 13(5):817-27. PubMed ID: 25012620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: Nature's most versatile biological signal?
    Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
    FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melatonin as a drug: present-day status and prospects].
    Arushanian ÉB
    Eksp Klin Farmakol; 2013; 76(9):32-7. PubMed ID: 24432567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and the aging brain.
    Bondy SC; Sharman EH
    Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders.
    Walia V; Chaudhary SK; Kumar Sethiya N
    Neurochem Int; 2021 Feb; 143():104939. PubMed ID: 33346032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress.
    Colin-Gonzalez AL; Aguilera G; Serratos IN; Escribano BM; Santamaria A; Tunez I
    Curr Pharm Des; 2015; 21(24):3477-88. PubMed ID: 26144936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs.
    Alamdari AF; Rahnemayan S; Rajabi H; Vahed N; Kashani HRK; Rezabakhsh A; Sanaie S
    Pharmacol Res; 2021 Nov; 173():105839. PubMed ID: 34418564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of melatonin in the brain of the senescence-accelerated mice-prone 8 (SAMP8) model].
    Gutierrez-Cuesta J; Tajes M; Jimenez A; Camins A; Pallas M
    Rev Neurol; 2011 May; 52(10):618-22. PubMed ID: 21488009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants and neuroprotection in the adult and developing central nervous system.
    Kaur C; Ling EA
    Curr Med Chem; 2008; 15(29):3068-80. PubMed ID: 19075654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.